These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9622092)
1. Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor. Hongo A; Yumet G; Resnicoff M; Romano G; O'Connor R; Baserga R Cancer Res; 1998 Jun; 58(11):2477-84. PubMed ID: 9622092 [TBL] [Abstract][Full Text] [Related]
2. Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells. Liu Y; Lehar S; Corvi C; Payne G; O'Connor R Cancer Res; 1998 Feb; 58(3):570-6. PubMed ID: 9458107 [TBL] [Abstract][Full Text] [Related]
3. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Lee CT; Wu S; Gabrilovich D; Chen H; Nadaf-Rahrov S; Ciernik IF; Carbone DP Cancer Res; 1996 Jul; 56(13):3038-41. PubMed ID: 8674059 [TBL] [Abstract][Full Text] [Related]
5. Synthetic peptide sequence from the C-terminus of the insulin-like growth factor-I receptor that induces apoptosis and inhibition of tumor growth. Reiss K; Yumet G; Shan S; Huang Z; Alnemri E; Srinivasula SM; Wang JY; Morrione A; Baserga R J Cell Physiol; 1999 Oct; 181(1):124-35. PubMed ID: 10457360 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines. Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665 [TBL] [Abstract][Full Text] [Related]
7. [Combinational effects of K-ras and IGF-IR antisense oligodeoxynucleotide on proliferation and apoptosis of human pancreatic cancer Patu8988 cells]. Shen YM; Yang XC; Zhang MH; Shen JK; Sun YH Ai Zheng; 2008 May; 27(5):496-504. PubMed ID: 18479599 [TBL] [Abstract][Full Text] [Related]
8. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor. Surmacz E; Sell C; Swantek J; Kato H; Roberts CT; LeRoith D; Baserga R Exp Cell Res; 1995 May; 218(1):370-80. PubMed ID: 7737373 [TBL] [Abstract][Full Text] [Related]
9. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins. Dews M; Nishimoto I; Baserga R Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824 [TBL] [Abstract][Full Text] [Related]
10. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors. Chen H; Yan GC; Gishizky ML Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246 [TBL] [Abstract][Full Text] [Related]
11. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. D'Ambrosio C; Ferber A; Resnicoff M; Baserga R Cancer Res; 1996 Sep; 56(17):4013-20. PubMed ID: 8752172 [TBL] [Abstract][Full Text] [Related]
12. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression. Coppola D; Saunders B; Fu L; Mao W; Nicosia SV Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. Reiss K; D'Ambrosio C; Tu X; Tu C; Baserga R Clin Cancer Res; 1998 Nov; 4(11):2647-55. PubMed ID: 9829727 [TBL] [Abstract][Full Text] [Related]
14. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Resnicoff M; Burgaud JL; Rotman HL; Abraham D; Baserga R Cancer Res; 1995 Sep; 55(17):3739-41. PubMed ID: 7641185 [TBL] [Abstract][Full Text] [Related]
15. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo. Chernicky CL; Yi L; Tan H; Gan SU; Ilan J Cancer Gene Ther; 2000 Mar; 7(3):384-95. PubMed ID: 10766344 [TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Resnicoff M; Coppola D; Sell C; Rubin R; Ferrone S; Baserga R Cancer Res; 1994 Sep; 54(18):4848-50. PubMed ID: 8069850 [TBL] [Abstract][Full Text] [Related]
17. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice. Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802 [TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect of IGF1R siRNA on the growth of human liver cancer SMMC7721 cell xenograft in nude mice]. Niu J; Qian HX; Li XN; Han ZG Ai Zheng; 2007 Jul; 26(7):703-8. PubMed ID: 17626744 [TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Singleton JR; Randolph AE; Feldman EL Cancer Res; 1996 Oct; 56(19):4522-9. PubMed ID: 8813151 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]